ROBERT L. ZERBE MD - 22 Jan 2024 Form 4 Insider Report for Vericel Corp (VCEL)

Role
Director
Signature
/s/ Sean Flynn, as Attorney-in-Fact for Robert Zerbe
Issuer symbol
VCEL
Transactions as of
22 Jan 2024
Net transactions value
-$322,415
Form type
4
Filing time
24 Jan 2024, 16:05:43 UTC
Previous filing
16 Jan 2024
Next filing
29 Jan 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VCEL Common Stock Sale $103,475 -2,500 -8.1% $41.39 28,395 22 Jan 2024 Direct F1
transaction VCEL Common Stock Sale $105,150 -2,500 -8.8% $42.06 25,895 22 Jan 2024 Direct F1
transaction VCEL Common Stock Options Exercise $12,360 +3,000 +12% $4.12* 28,895 22 Jan 2024 Direct
transaction VCEL Common Stock Sale $126,150 -3,000 -10% $42.05 25,895 22 Jan 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCEL Stock Option (Right to Buy) Options Exercise $0 +3,000 $0.000000* 0 22 Jan 2024 Common Stock 3,000 $4.12 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023.
F2 These options, representing the right to purchase 3,000 shares, became exercisable in equal monthly installments, contingent upon continued service to the Company, with the first vesting date on June 7, 2014, which was one month after the date on which the option was granted.
F3 These options, which were awarded on May 7, 2014, would otherwise expire and become forfeitable on May 7, 2024.